Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04478279 |
Title | A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Sapience Therapeutics |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA | GBR |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of California, San Francisco | San Francisco | California | 94143 | United States | Details | |
Sarah Cannon Research Institute | Denver | Colorado | 80218 | United States | Details | |
Northwestern Medicine Cancer Centers | Warrenville | Illinois | 60555 | United States | Details | |
START Midwest | Grand Rapids | Michigan | 49503 | United States | Details | |
Columbia University | New York | New York | 10032 | United States | Details | |
Duke University School of Medicine | Durham | North Carolina | 27708 | United States | Details | |
Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | United States | Details | |
Edinburgh Cancer Centre | Edinburgh | EH4 2SP | United Kingdom | Details | ||
The Beaston West of Scotland Cancer Centre | Glasgow | G12 0YN | United Kingdom | Details | ||
University of Leeds | Leeds | LS9 7TF | United Kingdom | Details | ||
Sarah Cannon Research Institute UK | London | W1G 6AD | United Kingdom | Details |